The cellular tumor antigen p53 is bound to the simian virus 40 (SV40) large T-antigen in SV40-infected and -transformed cells. As a result, p53 can in general be immunoprecipitated by either monoclonal or polyclonal antibodies that react with large T-antigen. Despite extensive immunological characterization of both these antigens, they have not previously been found to share any antigenic determinants. We have isolated several monoclonal antibodies that bind to the human p53 protein (K. Leppard and L. V. Crawford, EMBO J. 2:1457EMBO J. 2: -1464EMBO J. 2: , 1983) and show here that antibody PAb11O4 has distinct, intrinsic activities towards both p53 and SV40 large T-antigen. Only a subset of T-antigen is bound by PAb1104. This subset is an oligomeric form of T-antigen, as judged by its sedimentation velocity in sucrose. In contrast, all of the detectable p53 carries the PAb11O4-reactive determinant. The detection of a chance cross-reactivity between two antigens that are already well characterized and which associate with one another in vivo is highly unlikely. It is possible therefore that the element of structural similarity between large T and p53 that is implied by our results has some genuine functional significance.
Simian virus 40 (SV40) expresses two proteins, large Tand small t-antigens, from the early half of its genome (4, 15) . Antibodies to both these proteins are produced by animals bearing SV40-induced tumors (5, 15, 39, 44) . Such antisera immunoprecipitate large T-and small t-antigens from lysates of metabolically labeled SV40-transformed cells (15, 45) . In addition, such immunoprecipitates contain a specifically precipitated protein of 45,000 to 55,000 (45k to 55k) molecular weight, the precise size of which depends on cell type (7, 9, 22, 37) . This protein is now termed p53 and is known to be cellular in origin (33, 42, 43) . It is generally present in immunoprecipitates of SV40-transformed cell extracts because of its physical association with large T-antigen (28, 33, 36) . However, some anti-SV40 tumor sera, as well as some antisera from animals bearing tumors of diverse origin and from human cancer patients, contain intrinsic anti-p53 antibodies (17, 19, 28, 33) . It is still not known why p53 becomes immunogenic in a tumor-bearing animal, but since many rodent and human tumor cell lines and tumors contain elevated levels of p53 as compared with levels in control cells and tissues (3, 14, 18, 40) , it is possible that the normal process of self-tolerance is broken down by exposure to p53 released from necrotic tumor tissue. Alternatively, p53 from tumors and transformed cells may be structurally distinct from that found in normal cells, causing it to be recognized as foreign by the immune system of the animal.
After the initial detection of the SV40 tumor antigens and p53 with antitumor sera, a large number of monoclonal antibodies have been raised to these proteins (10, 20, 23, 24, 29, 32, 34, 41 ; L. Gooding, J. Pipas, and E. Harlow, manuscript in preparation). By use of these antibodies, at least 14 distinct antigenic determinants on large T-antigen (24; Gooding et al., in preparation; E. Harlow, personal communication), 4 determinants on rodent p53 (3) , and 3 determinants on human p53 (32) er, despite this very extensive immunological characterization of SV40 large T and p53, there has previously been no evidence of any immunological relationship between these two proteins. We report here the properties of a monoclonal antibody, PAb11O4, raised against human p53 (32) that binds to both human p53 and SV40 large T-antigen, each in the absence of the other. The PAbl1O4-reactive large T is a subset of the total non-p53-associated T-antigen in both SV40-infected, permissive and SV40-transformed, nonpermissive cells. This subset migrates on a sucrose gradient with a sedimentation coefficient of ca. 16S. Our results imply that p53 shares an element of structure with an oligomeric form of SV40 large T-antigen.
MATERIALS AND METHODS Cells, virus, and antibodies. The virus and cell lines used, and the conditions employed for cell culture, have been previously described (32) . Antibodies of the PAb400 series were isolated by Harlow et al. (24) , antibody PAb122 was isolated by Gurney et al. (23) , and all were kindly provided by Ed Harlow. Antibodies of the PAb200 series were isolated and provided by David Lane (10, 29) ; those of the PAb600 series were isolated and provided by Linda Gooding (Gooding et al., in preparation). Antibody RA3-2C2 was isolated and provided by Robert Coffman (12) . Antibodies PAb122, PAb410, PAb421, PAb6O7, and RA3-2C2 have anti-p53 activity, restricted in the latter two cases to mouse p53. Other antibodies of the PAb200, PAb400, and PAb600 series have activity towards SV40 large T-antigen. The isolation of PAb11O4 has been previously described (32 (27) , all as previously described (32) . Lysis buffer for preparation of cell extracts was 1% Nonidet P-40-150 mM NaCI-50 mM Tris (pH 8.0). NET gel buffer was 150 mM NaCl-5 mM EDTA-50 mM Tris (pH 7.4)-0.05% Nonidet P-40-0.02% NaN3-0.25% gelatin. A 10% suspension of Staphylococcus aureus Cowan 1 (26) phoresis were "C-labeled phosphorylase b (92k), glutamate dehydrogenase (53k), carbonic anhydrase (30k), soybean trypsin inhibitor (21k), cytochrome c (12.5k), and aprotinin (6.5k). 3H-labeled proteins were visualized by fluorography (6) , and other labeled proteins were visualized by autoradiography of dried gels.
Sucrose gradient analysis. Labeled proteins were in some cases separated by velocity sedimentation through sucrose before immunoprecipitation. A 0.3-ml portion of labeled cell lysate was layered over a 4.4-ml, linear, 5 to 20% sucrose gradient, formed in lysis buffer containing 1 mM dithiothreitol on a 0.3-ml cushion of 60% sucrose. Gradients were then resolved by centrifugation in a Beckman SW55 rotor for 6 h at 55k rpm at +6°C. Gradients were collected in ca. 0.2-ml fractions, which were then divided as required for parallel immunoprecipitation. Parallel gradients were calibrated with marker proteins of sedimentation coefficients 26S (glutamate dehydrogenase), 13.5S (phosphorylase a), and 7S (immunoglobulin G).
Radioimmunoassay. Procedures for determining the class of antibody PAb11O4, and the relationship of the determinant it recognizes to others already characterized, were as described previously (13, 24, 32) . Solution binding assays were performed as described by Harlow et al. (24) , modified from Lane and Robbins (31) .
RESULTS
PAb11O4 recognizes both p53 and T-antigen. The isolation of hybridoma PAb11O4 has already been described in detail (32) . The splenocyte parent of this hybridoma was derived from a BALB/c mouse immunized with p53 from the human SV40-transformed cell line SV80 that was purified by immunoprecipitation and SDS gel electrophoresis. PAb11O4 was cloned by using the ability of its secreted antibody to immunoprecipitate the large T-p53 complex from 32P-labeled SV80 cell lysate as a screen. It was found to produce an immunoglobulin M antibody that did not bind to S. aureus protein A.
To determine which of the two known components of the SV80 T-p53 complex was recognized by PAb11O4, immunoprecipitation reactions were performed with SV80 lysates that had been precleared of either T-antigen or p53. As shown in Fig. 1 Single antibody has anti-T and anti-p53 activities. During the isolation of hybridoma PAb11O4, cells were cloned three times, until they were monoclonal. However, to exclude the remote possibility that the dual activity of PAb11O4 resulted from the secretion of a mixed population of antibodies by the hybridoma cells, we metabolically labeled PAb11O4 with
[35S]methionine and determined which labeled species were capable of binding to large T and p53 (Fig. 2 (Fig. 3A) , PAb421 (B), PAb416 (C), and PAb4O2 (D). Each panel shows, from left to right, the precipitation profile from bottom to top of the gradient.
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The association of monkey p53 with SV40 T-antigen is NE known to be very weak (25) . As a result, any T-p53 complex initially present in the extracts analyzed here had dissociated -53 before the immunoprecipitation of gradient fractions, shown by the failure of anti-p53 antibody PAb421 to achieve any significant precipitation of T-antigen (Fig. 3B) . The observed precipitation of T-antigen by PAb11O4 from fractions of a parallel gradient (Fig. 3A) must therefore be attributed to the direct anti-T activity of this antibody. Antibodies PAb416 and PAb4O2 recognize determinants in the N-and C-terminal halves of T-antigen, respectively (24 PAb11O4 is highly specific for large T and p53. It was possible that PAb11O4 was a widely cross-reactive antibody, recognizing a very simple determinant, and that the apparently specific immunoprecipitation of large T and p53 by PAb11O4 was due to the highly selective labeling of proteins achieved with 32p;. In this regard, we had already noted the specific precipitation by PAb11O4 of phosphoproteins of molecular weight 60k and 55k (60K and 55K phosphoproteins) (Fig. 3A and 4A) . Titration experiments suggested that the affinity of PAb11O4 for these cellular proteins, which seemed from their comigration on sucrose gradients to be associated, was considerably lower than for either large T or p53, since precipitation of the 60K-55K complex was only observed at high antibody inputs; no similarity between p53, 60K, and 55K could be detected by V8 protease partial digestion analysis. To test the possibility that PAb11O4 might be widely cross-reactive, SV80 cells were labeled with [3H]leucine, which should label many more proteins than would 32p;, and extracts were immunoprecipitated with PAb11O4 and control antibodies (Fig. 5) . RA3-2C2 is a negative control in this system since it does not bind to human p53. The only proteins precipitated by PAb11O4 and not by RA3-2C2 (apart from large T and p53) were, as indicated, a very high-molecular-weight protein and proteins of 21.5k and 20k. The 21.5k protein was also precipitated by PAb419, which additionally precipitated a 14k protein. RA3-2C2 precipitated a protein of ca. 6k. There were no qualitative differences in the immunoprecipitation observed when labeling was carried out for 30 min, with or without prior depletion of leucine pools for 30 min. The 60K-SSK phosphoprotein complex, which cross-reacts with PAb11O4 as noted above, was not precipitated in this experiment, probably because inputs of PAb11O4 were below the amounts required for its detection. Although one cannot exclude the possibility that other specifically precipitated proteins might have been detected under different labeling conditions, we believe C.
A. from metabolically labeled SV80 cells by immunoprecipitation, gel electrophoresis, and passive elution and used these as antigens in a solution binding assay (24, 31) . The positive control antibodies rebound 75 and 36% of the large-T and p53 probes, respectively (Fig. 6) . In parallel experiments, PAb11O4 bound only 5% of large T and 17% of p53, whereas negative control antibodies bound only 5% of each probe. Thus the PAb11O4 determinant on large T was completely destroyed by SDS denaturation, as one would expect since PAb11O4 binds only to an oligomeric form of large T. In contrast, a proportion of the p53 probe was rebound by PAb11O4, suggesting that the relevant structure elements in this protein can at least partly refold under the assay conditions employed. DISCUSSION
We have presented evidence that a monoclonal antibody, PAb11O4, has dual reactivity towards p53 and an oligomeric form of SV40 large T-antigen, suggesting that these antigens have some element of structure in common. There are, however, at least two alternative explanations of the data that, although less likely, cannot yet be excluded. First, it is these data indicate that PAb11O4 is not widely cross-reactive and that its dual reactivity for large T and p53 shows that a significant element of structural similarity exists between these two proteins. A characteristic of all the anti-T monoclonal antibodies that have so far been shown to cross-react with cellular proteins is that they recognize determinants that survive SDS denaturation (16) , judged by their ability to rebind [35S]methionine-labeled antigen after elution from an SDSpolyacrylamide gel. To test the ability of PAb11O4 to bind denatured antigen, we prepared 35S-labeled large T and p53 of PAb421 (lanes a and f), PAb122 (lanes b and g), RA3-2C2 (lanes c and h), PAb419 (lanes e and j), or 10 p.l of PAb11O4 (lanes d and i) . After resuspension in sample buffer, each precipitate was divided into two parts, and one part was separated on a 7% polyacrylamide-SDS gel (lanes a through e), and the other was separated on a 12% polyacrylamide-SDS gel (lanes f through j). Precipitated proteins were detected by fluorography (6) , PPO (2,5-diphenyloxazole)-impregnated gels being exposed for 3 days to preflashed Fuji RX film at -70°C. The positions to which protein molecular weight markers migrated are indicated by arrows, 92k and 53k on the left, and 92k, 53k, 30k, 21k, 12.5k, and 6.5k on the right of the diagram. Among examples of this phenomenon are a number of antibodies that react with SV40 large T-antigen and various cellular proteins (16, 29 region of association between T and p53, then such regions but it cannot be must also remain exposed on some of the monomers of the )f total p53 and T-p53 complex to allow precipitation by the antibody. Studer, this putative ies on the maturation of the T-p53 complex in wild-type ould not be la-SV40 and tsA58-transformed mouse cells suggest that aslabeling for 30 sembly of a large-T oligomer may be an essential intermediore regard this ate step in generating the T-p53 complex (8, 21) , whereas ile that p53 and studies of in vitro complex formation with the purified Timon the ability antigen from adeno-SV40 hybrid virus Ad2+D2 show that the cell, eitherprobably limited. Preliminary data suggest that PAb11O4 can bind to D2 protein, which lacks the N-terminal 82 amino acids of large T, whereas, in blocking studies with anti-T antibodies of the PAb200 series (10, 29) , the PAb400 series (24) , and the PAb600 series (Gooding et al., in preparation) with T-antigen from a lysate of SV-S-infected CV1 cells as antigen, only one antibody, PAb427, showed blocking of PAb11O4 binding. The binding site of this antibody was mapped to the C-terminal portion of large T by its ability to bind the Ad2+ ND1 28K hybrid protein (24) . Unfortunately, the PAb427 hybridoma line has since been lost, so that further experiments with it are not possible. Partial blocking of PAb11O4 binding to C331 p53 by the anti-p53 antibody PAb11O3 (32) was also observed.
32P-C331
It is clearly important to define as far as possible the binding sites for PAb11O4 on large T and p53 and to determine whether or not this antibody defines the region of association between these two proteins. An important step towards this goal will be the definition, by mutant analysis, of the region of T-antigen that is required for p53 binding.
Such information can then be correlated with the binding data for PAb11O4 and other antibodies that react with large T. The recent isolation of a large number of both deletion and point mutations in large T-antigen (38; K. Peden, personal communication) brings the definition of the p53-binding site on T-antigen that much closer. The combined application of deletion mutant and monoclonal antibody analyses will provide the best approach to determining the functional significance of the large T-p53 complex in the process of SV40-mediated transformation.
